FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1923 June 13, 2002 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kantarjian, H.

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia . The following persons should have been listed as authors: John Goldman (Hammersmith Hospital, Imperial College School of Medicine, London), Stephen G. O'Brien (Royal Victoria Infirmary, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom), Nigel Russell (City Hospital, Nottingham, United Kingdom), Thomas Fischer (Johannes Gutenberg Universität, Mainz, Germany), Oliver Ottmann (Johann Wolfgang Goethe-Universität, Frankfurt, Germany), Pascale Cony-Makhoul (Université Victor Segalen, Bordeaux, France), Thierry Facon (Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France), Richard Stone (Dana–Farber Cancer Institute, Boston), Carole Miller (Johns Hopkins Oncology Center, . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.